SIMCERE PHARMACEUTICAL GROUP Accounts and Financing Receivable, after Allowance for Credit Loss, Current
SIMCERE PHARMACEUTICAL GROUP had Accounts and Financing Receivable, after Allowance for Credit Loss, Current of CNY 1.09 billion as of 2012-12-31, per its 20-F filed 2013-04-26.
Discontinued › Balance Sheet › Assets › Assets, Current › Accounts and Financing Receivable, after Allowance for Credit Loss, Current
us-gaap:AccountsNotesAndLoansReceivableNetCurrent · last filed 2013-04-26
- 2012-12-31: Accounts and Financing Receivable, after Allowance for Credit Loss, Current 1.09B CNY.
- 2011-12-31: Accounts and Financing Receivable, after Allowance for Credit Loss, Current 1.28B CNY.
- 2010-12-31: Accounts and Financing Receivable, after Allowance for Credit Loss, Current 884.74M CNY.
CNY
| Period end | Accounts and Financing Receivable, after Allowance for Credit Loss, Current |
|---|---|
| 2012-12-31 | 1.09B CNY 20-F · filed 2013-04-26 |
| 2011-12-31 | 1.28B CNY 20-F · filed 2013-04-26 |
| 2010-12-31 | 884.74M CNY 20-F · filed 2012-04-25 |
USD
| Period end | Accounts and Financing Receivable, after Allowance for Credit Loss, Current |
|---|---|
| 2012-12-31 | $175.46M 20-F · filed 2013-04-26 |